GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Price-to-Owner-Earnings

BIOA (Bioage Labs) Price-to-Owner-Earnings : (As of Mar. 27, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs Price-to-Owner-Earnings?

As of today (2025-03-27), Bioage Labs's share price is $3.91. Bioage Labs does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Bioage Labs's Price-to-Owner-Earnings or its related term are showing as below:


BIOA's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 23.24
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-03-27), Bioage Labs's share price is $3.91. Bioage Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-8.07. Therefore, Bioage Labs's PE Ratio (TTM) for today is At Loss.

As of today (2025-03-27), Bioage Labs's share price is $3.91. Bioage Labs's EPS without NRI for the trailing twelve months (TTM) ended in was $-7.98. Therefore, Bioage Labs's PE Ratio without NRI for today is At Loss.


Bioage Labs Price-to-Owner-Earnings Historical Data

The historical data trend for Bioage Labs's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs Price-to-Owner-Earnings Chart

Bioage Labs Annual Data
Trend Dec22 Dec23 Dec24
Price-to-Owner-Earnings
- - -

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Bioage Labs's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Bioage Labs's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioage Labs's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioage Labs's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Bioage Labs's Price-to-Owner-Earnings falls into.


;

Bioage Labs Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Bioage Labs's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=3.91/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioage Labs  (NAS:BIOA) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Bioage Labs Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Bioage Labs's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioage Labs Business Description

Traded in Other Exchanges
N/A
Address
1445A South 50th Street, Richmond, CA, USA, 94804
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.

Bioage Labs Headlines

From GuruFocus